Teva (TEVA) in Advanced Talks to Buy Allergan’s (AGN) Generic Drug Business: Source

According to a Reuters report that references ‘sources familiar with the matter’, Teva Pharmaceuticals (TEVA) is in advanced talks to buy the generic drug unit of Allergan (AGN) for between $40 billion and $45 billion. A deal could be announced as early as next week, the report said, cautioning that negotiations had not yet been […] View the full post at: Teva (TEVA) in Advanced Talks to Buy Allergan’s (AGN) Generic Drug Business: Source Related posts: Prudential in Advanced Talks to Buy AIG’s AIA for $35.5B BofA in Advanced Talks to Acquire Merrill Lynch Is Google In Talks to Acquire Twitter ; Two Prominent Blogs Clash Over Source Reliability